Improving appropriate use of intravenous albumin: results of a single-centre audit and multifaceted intervention.

Corey M ForsterShannon HallsSabrina AllarakhiaDimpy ModiWiley ChungKendra DerryGenevieve DigbyJennifer FlemmingJohn McGuganHeather MackulinSteven MontagueStephanie SibleySamuel A SilverAngela Sirosky-YanykAndrew StevensKerstin de WitLiying ZhangJeannie L Callum

Published in: BMJ open quality (2024)

Improved prescribing of albumin was achieved with a multifaceted approach. Substantial and sustained reductions in usage were achieved without negatively impacting patient-important outcomes. The estimated annual savings for the purchase cost of albumin was CAN $300 000. We provide a structured process for other organisations to optimise their use of albumin.

Keyphrases

randomized controlled trial
primary care
case report
type diabetes
emergency department
low dose
metabolic syndrome
skeletal muscle
insulin resistance